NUT Project: Nutritional Support in Thoracic Oncology
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCasa di Cura Dott. Pederzoli
About this trial
monitoring of the patient's nutritional status from diagnosis ensuring a dietetic-nutritional intervention throughout the treatment process
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men and women aged ≥ 18 years,
Diagnosis of advanced/metastatic non-small cell and small cell lung cancer candidates for first-line treatment of thoracic cancer
High nutritional risk according to NRS2002 screening test (score ≥3)
Nutritional assessment and care at the center
Disqualifiers
Lack of availability of information regarding anamnestic data,
Failure to sign informed consent
Trial population
Diagnosis of advanced/metastatic non-small cell and small cell lung cancer
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
nutritional status
Other interventionDuring the first visit, a nutritional screening test such as the Nutritional Risk Screening 2002 (NRS-2002) will be performed, which represents one of the main internationally validated screening tools (recommended by ESPEN and SINPE) for the risk of malnutrition. The test considers both the nutritional status and the degree of severity of the underlying pathology. Based on the final score: * patients with a score \< 3 will receive simple nutritional advice from the oncologist on the correct management of their diet during treatment. * patients with score ≥ 3 will be enrolled, after signing the informed consent, and subjected to a dietary - nutritional assessment as per clinical practice. This nutritional dietary assessment is composed of: 1. Use of GLIM criteria for the diagnosis of malnutrition 2. Nutrition data collections 3. Completion of questionnaires for data collection on health-related quality of life and data on oncological fatigue
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Describe the impact of dietary intervention and/or nutritional support on the nutritional status of patients during antiblastic treatments in terms of weight (kg)
Time frame
through study completion, an average of 1 year2
Describe the impact of dietary intervention and/or nutritional support on the nutritional status of patients during antiblastic treatments in terms of height (cm)
Time frame
through study completion, an average of 1 year3
Describe the impact of dietary intervention and/or nutritional support on the nutritional status of patients during antiblastic treatments in terms of BMI (kg/m^2)
Time frame
through study completion, an average of 1 year4
Describe the impact of dietary intervention and/or nutritional support on the nutritional status of patients during antiblastic treatments in terms of fatigue (Units on a Scale)
Time frame
through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov